1. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy 
Chantae Sullivan-Pyke, M.D., Daniel J. Haisenleder, Ph.D., Suneeta Senapati, M.D., M.S.C.E., Olivia Nicolais, B.A., Esther Eisenberg, M.D., M.P.H., Mary D. Sammel, Sc.D., Kurt T. Barnhart, M.D., M.S.C.E. 
Fertility and Sterility 
Volume 109, Issue 1, Pages e2 (January 2018)
DOI: /j.fertnstert
Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Receiver operating characteristic curve analysis of the performance of serum kisspeptin and serum hCG. AUC = area under the ROC curve.
Fertility and Sterility  , e2DOI: ( /j.fertnstert )
Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Box plots comparing serum and plasma kisspeptin values in patients with intrauterine pregnancies (IUP) and miscarriages (spontaneous abortions; SAB).
Fertility and Sterility  , e2DOI: ( /j.fertnstert )
Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

4. Supplemental Figure 1
Scatter plot of linear regression of log hCG levels compared with log kisspeptin levels in miscarriage (spontaneous abortion; SAB) compared with intrauterine pregnancie (IUP).
Fertility and Sterility  , e2DOI: ( /j.fertnstert )
Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

5. Supplemental Figure 2
Box Plot comparing kisspeptin values in patients who went on to have normal pregnancies (IUP) compared with patients with miscarriages (SAB).
Fertility and Sterility  , e2DOI: ( /j.fertnstert )
Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions